Tailoring Immunotherapy Treatment of Synchronous Renal Cell Carcinoma (RCC) and Triple-Negative Breast Cancer (TNBC)
Joint Authors
Sheng, Iris Y.
Kruse, Megan
Leininger, Kathryn M.
Ornstein, Moshe C.
Source
Case Reports in Oncological Medicine
Issue
Vol. 2019, Issue 2019 (31 Dec. 2019), pp.1-2, 2 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2019-06-04
Country of Publication
Egypt
No. of Pages
2
Main Subjects
Abstract EN
Synchronous tumors are defined as two tumors arising concurrently or within six months of each other.
Reports of synchronous RCC and breast cancer are limited to nonmetastatic renal cell carcinoma (RCC) and hormone receptor-positive infiltrative ductal carcinoma.
We present the first case of synchronous metastatic renal cell carcinoma and metastatic triple-negative breast cancer, managed with a novel combination of immunotherapy and chemotherapy.
American Psychological Association (APA)
Sheng, Iris Y.& Kruse, Megan& Leininger, Kathryn M.& Ornstein, Moshe C.. 2019. Tailoring Immunotherapy Treatment of Synchronous Renal Cell Carcinoma (RCC) and Triple-Negative Breast Cancer (TNBC). Case Reports in Oncological Medicine،Vol. 2019, no. 2019, pp.1-2.
https://search.emarefa.net/detail/BIM-1142040
Modern Language Association (MLA)
Sheng, Iris Y.…[et al.]. Tailoring Immunotherapy Treatment of Synchronous Renal Cell Carcinoma (RCC) and Triple-Negative Breast Cancer (TNBC). Case Reports in Oncological Medicine No. 2019 (2019), pp.1-2.
https://search.emarefa.net/detail/BIM-1142040
American Medical Association (AMA)
Sheng, Iris Y.& Kruse, Megan& Leininger, Kathryn M.& Ornstein, Moshe C.. Tailoring Immunotherapy Treatment of Synchronous Renal Cell Carcinoma (RCC) and Triple-Negative Breast Cancer (TNBC). Case Reports in Oncological Medicine. 2019. Vol. 2019, no. 2019, pp.1-2.
https://search.emarefa.net/detail/BIM-1142040
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1142040
